Tenofovir Resistance in Treatment-Naïve: study 903 tenofovir vs d4T Slide Show Presentation

1/10/03

Click here to start Presentation

Table of Contents by slide

Genotypic and Phenotypic Characterization of Virologic Failure through 48 Weeks Among Treatment-Naïve Patients Taking Tenofovir DF or Stavudine in Combination with Lamivudine and Efavirenz

Study 903Introduction

Study 903Methods

Study 903 Design

Study 903 Results: 48 Week Efficacy Summary

Study 903 Results:Phenotypic Susceptibility of NRTIs in Presence of K65R (Virco Antivirogram, n=7)

Study 903 Results:Phenotypic Susceptibility of NRTIs in Presence of K65R (ViroLogic PhenoSense, n=6)

Study 903 Results:Impact of K65R on NRTI Phenotypes

Study 903 Results:Outcomes of TDF-Treated Patients with K65R (n=7)

Study 903 Results:Outcomes of TDF-Treated Patients with K65R (continued)

Study 903Conclusions

Study 903Conclusions

> Download presentation source here...